| S2717 |
CP-91149
|
CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.
|
-
Nat Commun, 2024, 15(1):1524
-
EMBO Rep, 2024, 10.1038/s44319-024-00278-4
-
Cell Rep, 2023, 42(6):112578
|
|
| S2045 |
Doxifluridine
|
Doxifluridine (5'-DFUR, AMC 0101) is an oral prodrug that is converted to the cytotoxic agent 5-fluorouracil (5-FU).
|
-
BIOCHIP J, 2023, 17, 284–292
-
Acta Histochem, 2022, 124(4):151895
-
Cell Metab, 2019, 29(5):1217-1231
|
|
| S3731 |
Tipiracil hydrochloride
|
Tipiracil (MA-1) is an inhibitor of thymidine phosphorylase, the enzyme that degrades trifluridine into trifluorothymidine. Its combination with trifluridine increases the bioavailability of trifluridine.
|
-
iScience, 2024, 27(10):110862
-
Cell Mol Immunol, 2022, 10.1038/s41423-022-00842-9
-
JCI Insight, 2022, 7(22e158060)
|
|
| S0031 |
Ingliforib
|
Ingliforib (CP 368296) is a glycogen phosphorylase (GP) inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
|
|
|
| S6510 |
Iso-H7 dihydrochloride
|
Iso-H7 dihydrochloride is an inhibitor of phosphokinase C.
|
|
|
| E6031 |
Tipiracil
|
Tipiracil is a thymidine phosphorylase (TPase) inhibitor.
|
|
|